Search

Your search keyword '"Billaud M"' showing total 283 results

Search Constraints

Start Over You searched for: Author "Billaud M" Remove constraint Author: "Billaud M"
283 results on '"Billaud M"'

Search Results

59. Posttranslational modifications in connexins and pannexins.

63. IL-4 induces LFA-1 and LFA-3 expression on Burkitt's lymphoma cell lines. Requirement of additional activation by phorbol myristate acetate for induction of homotypic cell adhesions

65. Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway.

67. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells.

68. Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2

69. Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex.

70. The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype

73. Real measures, virtual instruments

74. Integration of Remote Lab Exercises into Standard Course Packages.

75. Role of the gap junctions in the contractile response to agonists in pulmonary artery from two rat models of pulmonary hypertension

76. Signalling pathways involved in 5-HT-induced contraction dependent on connexin 43 and superoxide anion production in rat intrapulmonary arteries.

77. Role of Pannexin 1 in the regulation of blood pressure.

80. The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret

81. Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer

82. Is Co-option a prevailing mechanism during cancer progression?

83. Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors

84. Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase

85. The RET receptor: function in development and dysfunction in congenital malformation

86. Molecular mechanisms of Ret activation in human neoplasia

87. Leveraging investments, promoting transparency and mobilising communities: a qualitative analysis of news articles about how the Ebola outbreak informed COVID-19 response in five African countries.

89. A novel inhibitor of the mitochondrial respiratory complex I with uncoupling properties exerts potent antitumor activity.

90. Androgenic steroids induce pathologic scarring in a preclinical porcine model via dysfunctional extracellular matrix deposition.

91. Impact of rising seawater temperature on a phagocytic cell population during V. parahaemolyticus infection in the sea anemone E. pallida .

92. Functions of LKB1 in neural crest development: The story unfolds.

93. The TLR3 L412F polymorphism prevents TLR3-mediated tumor cell death induction in pediatric sarcomas.

94. [Preventable cancers: Is it enough to change our behaviour?]

95. Editorial: Women in heart valve disease.

96. BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1.

97. Amount of Pannexin 1 in Smooth Muscle Cells Regulates Sympathetic Nerve-Induced Vasoconstriction.

98. The Clostridium-infecting filamentous phage CAK1 genome analysis allows to define a new potential clade of Tubulavirales.

99. Adventitia-derived extracellular matrix hydrogel enhances contractility of human vasa vasorum-derived pericytes via α 2 β 1 integrin and TGFβ receptor.

100. Aortic Dissection is Determined by Specific Shape and Hemodynamic Interactions.

Catalog

Books, media, physical & digital resources